These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1619286)

  • 21. Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
    Donta ST; Peduzzi P; Cross AS; Sadoff J; Haakenson C; Cryz SJ; Kauffman C; Bradley S; Gafford G; Elliston D; Beam TR; John JF; Ribner B; Cantey R; Welsh CH; Ellison RT; Young EJ; Hamill RJ; Leaf H; Schein RM; Mulligan M; Johnson C; Abrutyn E; Griffiss JM; Slagle D
    J Infect Dis; 1996 Sep; 174(3):537-43. PubMed ID: 8769611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of the protective properties of antisera and immunoglobulin to antigens of Pseudomonas aeruginosa slime].
    Zaĭdner IG; Stanislavskiĭ ES; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):52-7. PubMed ID: 6778023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An experimental study of the activity of an anti-Pseudomonas aeruginosa immunoglobulin for intravenous administration].
    Kholodkova EV; Makarenko TA; Kuz'michev VA; Krokhina MA; Sarafanova LN; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):74-5. PubMed ID: 8079579
    [No Abstract]   [Full Text] [Related]  

  • 24. Is there a place for hyperimmune globulins in the treatment of refractory infections?
    Boyce N
    Transfus Med Rev; 2001 Apr; 15(2):157-68. PubMed ID: 11309735
    [No Abstract]   [Full Text] [Related]  

  • 25. [The differentiation of OEP-HA titer between gamma-globulin products for intravenous use and their effectiveness in the passive protection of mice against Pseudomonas aeruginosa infection (author's transl)].
    Haranaka K; Satomi N; Matsuo M; Fukaya K; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1978 Nov; 52(11):490-6. PubMed ID: 85678
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG.
    Eichberg JW; Murthy KK; Ward RH; Prince AM
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1515. PubMed ID: 1466993
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of i.v. immunoglobulins on experimental infections--especially in combination with antibiotics].
    Sunakawa K; Akita H; Yamashita N; Jozaki K; Iwata S; Iwasaki Y; Sato Y; Tojo M; Osano M; Ichihashi Y
    Kansenshogaku Zasshi; 1982 Dec; 56(12):1196-202. PubMed ID: 6820034
    [No Abstract]   [Full Text] [Related]  

  • 28. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN; Holder IA; Wiener-Kronish JP; Sawa T
    Burns; 2005 Mar; 31(2):153-8. PubMed ID: 15683685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological carrier improves passive protection of mice against Pseudomonas aeruginosa infection.
    Sourek J; Zelenková L; Pokorný J
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):105-10. PubMed ID: 1619286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
    Moss RB
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
    Cachia PJ; Hodges RS
    Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.